Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Frank Barletta
A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®
AAPS Journal
Pharmaceutical Science
Related publications
LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells
Journal of Immunology
Allergy
Immunology
A Novel Bispecific Single-Chain Antibody for ADAM17 and CD3 Induces T-Cell-Mediated Lysis of Prostate Cancer Cells
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Development of PF-06671008, a Highly Potent Anti-P-Cadherin/Anti-Cd3 Bispecific DART Molecule With Extended Half-Life for the Treatment of Cancer
Antibodies
Drug Discovery
Allergy
Immunology
Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition
Journal of Immunology
Allergy
Immunology
An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors
Science Translational Medicine
Medicine
A Bispecific Diabody Directed Against Prostate-Specific Membrane Antigen and CD3 Induces T-Cell Mediated Lysis of Prostate Cancer Cells
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
A Novel GUCY2C-CD3 T Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
Clinical Cancer Research
Cancer Research
Oncology
Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing
Cancers
Cancer Research
Oncology
Cancer Vaccines: The Molecular Basis for T Cell Killing of Tumor Cells
Oncologist
Cancer Research
Medicine
Oncology
